Market 32, Price Chopper campaign raises nearly $60K for Feeding America and Cure Rare Disease

Market 32, Price Chopper campaign raises nearly $60K for Feeding America and Cure Rare Disease

Market 32 and Price Chopper customers helped raise $59,529 by purchasing limited-edition, specially designed plush toys.
Market 32 and Price Chopper customers helped raise $59,529 by purchasing limited-edition, specially designed plush toys.
by The Packer Staff, May 30, 2025

Market 32 and Price Chopper customers helped raise $59,529 by purchasing limited-edition plush toys, with the funds set to benefit hunger-relief organization Feeding America and Cure Rare Disease, a nonprofit committed to developing customized genetic therapies for individuals living with rare disorders.

Customers could buy the toys in stores during the recent campaigns, with $3 from each sale supporting the the two organizations. Sales of plush dogs generated $34,455 to help provide meals to families facing hunger through Feeding America, while $25,074 from sales of plush ducks will support Cure Rare Disease, according to a news release.

“The positive response to our dogs and ducks, which resulted in vital funding, demonstrates a deep commitment our company and customers have to building healthier, stronger communities,” said Pam Cerrone, director of community relations for Market 32 and Price Chopper. “We’re grateful to be able to support organizations that fight hunger and advance life-saving medical research, and incredibly proud of the difference we make together.”

Diane Letson, vice president of food industry partnerships for Feeding America, said the effort to end hunger needs dedicated partners and a shared vision.

“With the help of Market 32 and Price Chopper’s continued partnership, Feeding America is helping provide neighbors with access to the food and resources they say they need to thrive,” Letson said.

Rich Horgan, founder, president and CEO of Cure Rare Disease, said the generosity of Market 32, Price Chopper and customers goes is an investment in hope for families affected by rare diseases.

“Business partnerships like this are critical in helping us develop potentially life-saving therapies that would otherwise go unfunded,” Horgan said. “We’re deeply grateful for their commitment to giving back and enabling the essential, urgent work of research and drug development for rare diseases.”









Become a Member Today